Emily de los Reyes
Quick facts
Phase 1 pipeline
- AAV9.SLC6A1 Gene Therapy · Neurology
AAV9-mediated delivery of the SLC6A1 gene to the brain
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: